Dexmedetomidine versus Magnesium Sulphate as an Adjuvant to Local Anesthesia in Single-Injection Percutaneous Peribulbar Anesthesia for Cataract Extractio
- Conditions
- Anaesthesia
- Registration Number
- PACTR202103648671596
- Lead Sponsor
- Faculty of Medicine Ain shams University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
•ASA physical status I, II AND III.
•Type of surgeries: Phacoemulsification surgeries for cataract extraction.
•Axial length of the globe (AXL) < 30 mm.
•ASA physical status IV & V.
•Axial length (AXL) of the globe >30 mm.
•Patients with contraindications to the block (with bleeding tendencies or on anticoagulant drugs, with infection at the site of injection or allergies to the test drugs).
•Patients who could not lie flat for long periods of time.
•Patients with tremors or agitation.
•Patients with communication difficulties such as mental retardation, deafness, or disturbed conscious level.
•Patients with single-seeing eye.
•Prolonged or complicated surgeries duration > 3 hours.
•Patients refusing to be included in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To prove that adding dexmedetomidine or magnesium sulphate to the anesthetic mixture in peribulbar block will enhance the quality & the duration of the peribulbar block .
- Secondary Outcome Measures
Name Time Method to compare between the effects of dexmedetomidine versus magnesium sulphate as an adjuvants to single-injection peribulbar anesthesia as a secondary goal.